The PTEN Hamartoma Tumor Syndrome Foundation was founded to find treatments or therapies for PTEN Syndromes by funding research, PHTS program development, supporting patients, and by raising awareness. PTEN Hamartoma Tumor syndrome (PHTS) is a rare genetic condition that causes increased risk for certain cancers, benign growths, and neurodevelopmental conditions.

Kristin Anthony
CEO & President

All resident associate companies on the HudsonAlpha campus are independently owned and operated.